Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3048

Actual shortage: 226 (7%)
Anticipated shortage: 14 (0%)
Avoided shortage: 9 (0%)
Resolved: 2799 (92%)

Discontinuation Reports

356

To be discontinued: 22 (6%)
Discontinued: 334 (94%)
Reversed: 0 (0%)

Late reports

142 (4%)

Overdue reports

31 (12%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-GLICLAZIDE 80MG TABLET Actual shortage 2024-04-05 2024-04-26 224583
APO-GLICLAZIDE 80MG TABLET Actual shortage 2024-04-19 2024-04-19 225799
APO-ATORVASTATIN 80MG TABLET Resolved 2024-05-03 2024-05-24 227088
APO-ATORVASTATIN 80MG TABLET Resolved 2024-05-10 2024-05-24 227725
APO-VERAP TAB 80MG 80MG TABLET Actual shortage 2024-05-24 2024-05-24 228810
APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE 850MG 50MG TABLET Resolved 2023-03-02 2023-10-06 185951
APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE 850MG 50MG TABLET Resolved 2023-03-02 2023-10-06 185954
APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE 850MG 50MG TABLET Resolved 2023-10-20 2023-12-22 207686
APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE 850MG 50MG TABLET Resolved 2023-10-20 2023-12-22 207689
APO-AMOXI CLAV 875MG 125MG TABLET Resolved 2017-03-11 2017-04-25 636
APO-AMOXI CLAV 875MG 125MG TABLET Resolved 2017-06-05 2017-09-05 11959
APO-AMOXI CLAV 875MG 125MG TABLET Resolved 2018-02-05 2018-04-18 38473
APO-AMOXI CLAV 875MG 125MG TABLET Resolved 2019-06-19 2019-09-23 87057
APO-PERINDOPRIL-INDAPAMIDE 8MG 2.5MG TABLET Resolved 2022-04-29 2022-06-28 159713
APO-PERINDOPRIL-INDAPAMIDE 8MG 2.5MG TABLET Avoided shortage 2023-03-09 2023-09-15 186580
APO-PERINDOPRIL-INDAPAMIDE 8MG 2.5MG TABLET Resolved 2023-03-09 2023-09-22 186583
APO-PERINDOPRIL-INDAPAMIDE 8MG 2.5MG TABLET Resolved 2023-10-27 2024-02-09 208411
APO-HYDROMORPHONE 8MG TABLET Resolved 2017-07-31 2017-09-06 17605
APO-CANDESARTAN 8MG TABLET Resolved 2017-08-08 2020-02-25 18520
APO-ONDANSETRON 8MG TABLET Resolved 2018-03-13 2018-09-29 42697

Showing 3001 to 3020 of 3048

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-TERAZOSIN 2MG TABLET Discontinued 2017-03-31 2018-02-05 4974
APO-SALVENT TABLETS - 2MG 2MG TABLET Discontinued 2018-02-23 2018-12-28 40854
APO-TOLTERODINE 2MG TABLET Discontinued 2018-09-08 2018-11-09 60825
APO-TOLTERODINE 2MG TABLET Discontinued 2018-09-08 2019-06-12 60828
APO-RISPERIDONE 3.0MG TABLET Discontinued 2018-09-08 2019-06-12 60750
APO-CARVEDILOL 3.125MG TABLET To be discontinued 2024-01-26 2024-01-26 217496
APO-ABACAVIR-LAMIVUDINE-ZIDOVUDINE 300MG 150MG 300MG TABLET Discontinued 2022-12-12 2022-12-12 177953
APO-DILTIAZ TZ 300MG CAPSULE (EXTENDED RELEASE) Discontinued 2017-03-13 2017-03-13 1075
APO-NIZATIDINE 300MG CAPSULE Discontinued 2017-03-13 2017-03-13 1135
APO-GEMFIBROZIL CAP 300MG USP 300MG CAPSULE Discontinued 2017-03-31 2018-12-07 4920
APO-CLINDAMYCIN 300MG CAPSULE Discontinued 2018-09-07 2019-07-13 60399
APO-IBUPROFEN 300MG TABLET Discontinued 2018-09-07 2018-09-15 60527
APO-IRBESARTAN 300MG TABLET Discontinued 2018-09-07 2018-09-15 60539
APO-LAMIVUDINE 300MG TABLET Discontinued 2018-09-07 2019-07-13 60560
APO-LITHIUM CARBONATE 300MG CAPSULE Discontinued 2018-09-07 2018-09-15 60588
APO-QUETIAPINE 300MG TABLET Discontinued 2018-09-08 2018-12-28 60708
APO-QUININE 300MG CAPSULE Discontinued 2018-09-08 2021-05-10 60714
APO-RANITIDINE TABLET 300MG 300MG TABLET Discontinued 2018-09-08 2018-09-15 60729
APO-RANITIDINE TABLET 300MG 300MG TABLET To be discontinued 2018-09-08 2018-09-08 60732
APO-IBUPROFEN 300MG TABLET Discontinued 2019-01-02 2019-01-02 70793

Showing 221 to 240 of 356